Project Grant R44GM143945
- This $239,530 Project Grant awarded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will enable the University of California, Davis (UC Davis) to acquire a Beckman Coulter CytoFlex Nano flow cytometer. This specialized instrument will enhance the capabilities of UC Davis's Flow Cytometry Shared Resource Laboratory to study small extracellular vesicles, such as exosomes, which play a critical role in cancer diagnosis, metastasis, and...
- This Project Grant award from the National Science Foundation (NSF) Integrative Activities program (CFDA 47.083) provides $210,034 to Portland State University to acquire a high-throughput flow cytometer. This instrument will enable the university to quantify individual cells and their properties within complex biological systems, supporting a range of research including water activity in cells, environmental stress impacts on coastal organisms, and detection of novel viruses and DNA replication...
- Partillion Bioscience Corp. was awarded a $659,037 Project Grant from the National Institutes of Health's National Institute of General Medical Sciences to develop reagent products enabling high-throughput screening and selection of single cells based on secreted bio-products. Under the Biomedical Research and Research Training program (CFDA 93.859), Partillion plans to transition its lab-on-a-particle technology—highlighted as a 2020 SLAS Innovation Award winner—into the first reagent product...
- Grant Award Summary FluoroFinder, LLC received a $348,492 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded July 2, 2025, with completion targeted for July 1, 2027. The company is developing the Matched Pair Tool, a digital workflow software designed to streamline the identification and selection of matched antibody pairs for immunoassay development. This tool addresses a critical...
- Federal Project Grant Award Summary The University of California, San Diego received a $454,942 Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a full-spectrum flow cytometer for the Human Embryonic Stem Cell Core Facility (HESCCF) at the Sanford Consortium for Regenerative Medicine (SCRM). The award, effective May 15, 2025 through May 14, 2026, funds the procurement of a Cytek Aurora full-spectrum...
- The National Science Foundation Office of Integrative Activities awarded a $208,678 Project Grant to Northern Kentucky University (NKU), a primarily undergraduate institution, for the acquisition of a Miltenyi Biotec MACSQuant Vyw digital benchtop flow cytometer. This sophisticated equipment will be used in NKU's biology and chemistry teaching laboratories, as well as to support faculty research and provide undergraduate research training opportunities. The flow cytometer will enable NKU...
- GRANT AWARD SUMMARY Panluminate Inc., a woman-owned small business headquartered in New Haven, Connecticut, received a $312,148 Project Grant from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) awarded August 1, 2025, with a completion date of July 31, 2026. The award funds development of AFLEX, an automated and multiplexed spatial proteomics imaging solution designed to overcome current limitations in resolution, throughput, sample...
- This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...
- Federal Grant Award Summary Kinetic River Corp. received a $2.0 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded July 15, 2025, with performance completion targeted for March 31, 2028. The award supports commercialization and refinement of the ARNO flow cytometer, an advanced analytical instrument designed to eliminate the need for spectral compensation in flow cytometry...
- The West Virginia University Research Corporation was awarded a $777,000 Project Grant from the National Institutes of Health Office of the Director to support the purchase of a Cytek 3-laser Aurora analytical flow cytometer. The flow cytometer will be operated by the West Virginia University Flow Cytometry & Single Cell Core Facility to support biomedical research projects funded by NIH grants across multiple programs. High usage of the facility's existing analytical cytometer has led to...
IMPROVED FLOW CYTOMETRY PANEL DESIGN WITH A NOVEL AUTOMATED PANEL DESIGN SYSTEM - PROJECT SUMMARY CYTOMETRY EXPERIMENTS ARE INCREASINGLY COMPLEX, OFTEN INVOLVING MORE THAN 20 UNIQUE PARAMETERS. FOR EXAMPLE, THE RECENT ADAPTION OF SPECTRAL FLOW CYTOMETRY MEANS 64 OR MORE CHANNELS WITH 40 SIMULTANEOUS FLUORESCENT PARAMETERS CURRENTLY VALIDATED IN OPTIMIZED MULTICOLOR IMMUNOFLUORESCENCE PANELS (OMIP)-069 HAVE >31 MILLION COMBINATIONS OF COMMERCIALLY AVAILABLE PRODUCTS FOR THESE MARKERS. SUCCESSFUL DESIGN OF COMPLEX MULTI-PARAM- ETER EXPERIMENTS REQUIRES EXTENSIVE KNOWLEDGE OF PANEL DESIGN PRINCIPLES TO ORGANIZE ANTIGENS BASED ON BIOLOG- ICAL DENSITY AND CELLULAR EXPRESSION PATTERNS. INSUFFICIENT USER EXPERIENCE AND POOR PANEL OPTIMIZATION CAN LEAD TO ERRORS IN EXPERIMENTAL DESIGN, RESULTING IN UNRELIABLE, INTERNALLY INCONSISTENT DATA. THESE ERRORS CAN COST THOU- SANDS OF DOLLARS AND OFTEN WASTE RARE OR LOW-VOLUME SAMPLES THAT MAY, IN SOME CASES, BE IRREPLACEABLE. RECENT WORK HAS ESTIMATED THAT THERE IS NEARLY $28.2 BILLION IN COSTS ASSOCIATED WITH IRREPRODUCIBLE PRECLINICAL WORK IN THE U.S. ALONE THAT IS PREDOMINANTLY ATTRIBUTED TO POOR ANTIBODY PERFORMANCE AND STUDY DESIGN. WITH THE GROWING COMPLEXITY OF FLOW CYTOMETRY EXPERIMENTS, THERE IS A NEED FOR AUTOMATED SOFTWARE THAT ACCELERATES AND OPTIMIZES THE EXPERIMENTAL DESIGN PROCESS, REDUCES ERRORS, AND LOWERS THE BARRIER TO ENTRY. WITH NIH PHASE I SUPPORT, FLUOROFINDER COMPLETED INITIAL DEVELOPMENT AND DEMONSTRATED PROOF-OF-CONCEPT FOR INTELLIPANEL, A HIGHLY CUSTOM- IZABLE TOOL FOR EFFICIENT AND OPTIMAL DESIGN OF FLOW CYTOMETRY ASSAYS THAT USES SPECTRAL OVERLAP AND BIOLOGICAL APPLICATION INFORMATION TO AUTOMATICALLY GENERATE A FLOW CYTOMETRY ASSAY FOR A GIVEN INSTRUMENT CONFIGURATION. FLUOROFINDER DEVELOPED THE FIRST VERSION OF INTELLIPANEL, CONDUCTED A COMPARISON OF AUTOGENERATED PANELS COM- PARED TO PUBLISHED OMIPS, AND SURVEYED EXPERT CYTOMETRISTS TO DEMONSTRATE 92% APPROVAL OF INTELLIPANEL RESULTS FOR UP TO 26 MARKERS. IN THIS PHASE II PROJECT, FLUOROFINDER WILL INTEGRATE ADDITIONAL PARAMETERS, EXPAND DATA- BASES, AND GENERATE USER FRIENDLY TOOLS THAT SIGNIFICANTLY IMPROVE THE ACCURACY OF INTELLIPANEL RECOMMENDATIONS FOR AUTOMATED PANELS WITH 26 TO 40 FLUORESCENT MARKERS AND WILL ADVANCE FEATURES TO IMPROVE STANDARDIZATION AND REPRODUCIBILITY IN THE FIELD THROUGH THE FOLLOWING AIMS: AIM 1: IMPROVE THE AUTOMATED EASE-OF-USE AND ACCU- RACY OF RECOMMENDATIONS THROUGH INTEGRATION OF THE ANTIGEN DENSITY DATABASE AND THE EXPANSION OF ADDITIONAL EXPERIMENTAL PARAMETERS. AIM 2: INTEGRATE A "CELL TYPE TO PANEL" FEATURE TO IMPROVE EXPERIMENTAL REPRODUCIBILITY. AIM 3: OPTIMIZE UX FOR COMPREHENSIVE EXPERIMENTAL RECOMMENDATIONS BASED ON USER CONFIGURATION. INTELLIPANEL IS EXPECTED TO YIELD SIGNIFICANT TIME AND COST SAVINGS, REDUCE OR ELIMINATE DESIGN ERRORS, AND LOWER THE BARRIER TO ENTRY FOR DEVELOPING SUCCESSFUL FLOW CYTOMETRY EXPERIMENTS. ULTIMATELY, THESE TOOLS WILL ENABLE THE STANDARDIZA- TION OF ASSAYS, PLATFORMS AND ANALYSIS THAT WILL LEAD TO MORE CONSISTENT AND RELIABLE HIGH PARAMETER FLOW EXPERI- MENTS AND EMERGING TECHNOLOGIES (E.G., >26 COLOR SPECTRAL FLOW CYTOMETRY).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 4/17/26 | ||
| Not listed | $1.3m | 5/27/25 | ||
| Not listed | $1.3m | 6/13/24 | ||
| Not listed | $1.3m | 6/13/24 |